| http://www.w3.org/ns/prov#value | - Two biosimilar mAbs are already launched, Dr. Reddy???s rituximab, Reditux was approved in India in 2007, and Clotinab, ISU ABXIS??? biosimilar form of abciximab is launched in 30 countries worldwide, including the US and EU. In addition, according to Citeline???s Pipeline database there are currently 49 biosimilar mAbs in the pipeline based on information that has been released in the public doma
|
